At Digestive Disease Week (DDW) 2019 in San Diego, CA, DDW commemorated its 50th year as the premier meeting in gastroenterology, hepatology and surgery. Nearly 14,000 attendees helped us celebrate over four days of networking and world-class education that featured 813 original sessions (oral and poster), 4,229 posters and 291 exhibitor booths.
R. Todd Stravitz, MD, FACP, FACG, FAASLD, and Jasmohan S. Bajaj, MD, AGAF, FACG, FAASLD, FRCP, discussed the management of acute liver failure and acute-on-chronic liver failure within the first 48 hours at an AASLD symposium on Monday, May 20, at DDW.
Although there are incredibly effective therapies for viral hepatitis, disruption of maternal to child transmission remains an important aspect of prevention. In this DDW News video, Nancy S. Reau, MD, FAASLD, discusses some of the challenges of treating expectant mothers with hepatitis B and C.
Michael R. Lucey, MD, FAASLD, will present Tuesday morning’s AASLD State-of-the-Art Lecture “Liver Transplantation for Extended Criteria Recipients.” The term ‘extended criteria’ is borrowed from the donor literature and doesn’t have a specific definition, he says.
To make sure attendees catch the most thought-provoking research at #DDW19, representatives from each of the four sponsoring societies will highlight the meeting’s top abstracts during Tuesday afternoon’s “Best of DDW 2019” session.
“All GI/hepatologists are asked to assist maternal fetal medicine in the care of pregnant women with liver disease, and as the prevalence of HCV increases and screening guidelines change, we are certain to be faced with this clinical dilemma more often,” says Nancy S. Reau, MD, FAASLD, who will co-moderate Tuesday’s AASLD Clinical Symposium “Managing HBV and HCV in Pregnancy.”
Nancy S. Reau, MD, FAASLD, discusses the worldwide prevalence of hepatitis B and hepatitis C during pregnancy, and points to some of the resources available to gastroenterologists treating expectant mothers with viral hepatitis.
Drug-induced liver injury is seen by every practicing gastroenterologist, not just liver specialists, according to Robert J. Fontana, MD, FAASLD, who will moderate Monday’s AASLD State-of-the-Art Lecture “Drug-Induced Liver Injury in the GI Practice.”
Varices and variceal hemorrhage are important and challenging complications that lead to decreased survival in patients with cirrhosis. Their proper management will lead to improvement in survival, according to presenters in Monday’s AASLD Clinical Symposium “Update on the Management of Gastroesophageal Varices.”
As Monday’s AASLD State-of-the-Art “New Hope for HCC” lecturer Laura Kulik, MD, notes, “15 years ago, an hour on the treatment of liver cancer would have been very difficult.” But now, a one-hour update is not only possible, but important for gastroenterologists.
